Ami Organics Limited Stock price

Equities

AMIORG

INE00FF01017

Diversified Chemicals

Delayed NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
1,094 INR -0.87% Intraday chart for Ami Organics Limited -1.70% -2.52%
Sales 2024 * 7.13B 85.58M Sales 2025 * 8.89B 107M Capitalization 40.34B 484M
Net income 2024 * 555M 6.66M Net income 2025 * 1.08B 13M EV / Sales 2024 * 5.66 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.54 x
P/E ratio 2024 *
61.4 x
P/E ratio 2025 *
37.1 x
Employees 602
Yield 2024 *
-
Yield 2025 *
-
Free-Float 41.82%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.87%
1 week-1.70%
Current month-1.90%
1 month-3.00%
3 months-5.26%
6 months-12.18%
Current year-2.52%
More quotes
1 week
1 080.95
Extreme 1080.95
1 142.00
1 month
1 004.45
Extreme 1004.45
1 194.00
Current year
1 004.45
Extreme 1004.45
1 194.00
1 year
885.60
Extreme 885.6
1 388.95
3 years
766.10
Extreme 766.1
1 434.45
5 years
766.10
Extreme 766.1
1 434.45
10 years
766.10
Extreme 766.1
1 434.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 04-01-02
Director of Finance/CFO 46 22-03-23
Chief Operating Officer 48 -
Members of the board TitleAgeSince
Director/Board Member 58 21-04-27
Chief Executive Officer 49 04-01-02
Founder 49 04-01-02
More insiders
Date Price Change Volume
24-03-28 1,094 -0.87% 84,388
24-03-27 1,103 -1.82% 103,627
24-03-26 1,124 -0.43% 111,430
24-03-22 1,129 +1.43% 98,130
24-03-21 1,113 -0.47% 77,343

Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT

More quotes
Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,094 INR
Average target price
1,298 INR
Spread / Average Target
+18.68%
Consensus
  1. Stock
  2. Equities
  3. Stock Ami Organics Limited - NSE India S.E.